Genpharmasec has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday 27th March, 2024 to transact the following businesses: To consider and take on record the resignation of Ulhas Deosthale from the post of Whole-Time Director; To consider and take on record the resignation of Heta Shah from the post of Company Secretary and Compliance Officer; To consider and approve the appointment of Company Secretary and Compliance Officer in place of Heta Shah; any other business with the permission of Chairperson.
The above information is a part of company’s filings submitted to BSE.
